Tim Doyle is co-founder and CEO of Eucalyptus. He started the company in 2019 with Benny Kleist, Alexey Mitko and Charlie Gearside. It is a digital health business based in Sydney.
Eucalyptus sells treatment through online clinics where a doctor consults and prescribes. Instead of one brand it runs four: Pilot, Juniper, Kin and Software. Its competitors include Hims & Hers, Ro, Mosh and Hey Doctor.
Funding came in steps. The Series A of A$8 million came in May 2020, the Series B of A$30 million in July 2021 and the Series C of A$60 million in January 2022. Investors include Blackbird, AirTree, W23, OneVentures, Athletic Ventures and Bond. In April 2023 a further A$50 million valued the company at about A$520 million.
The company posted an after-tax loss of A$15.2 million in the 2024 financial year. By 2025 its annual revenue run-rate was above $450 million (A$640 million). In February 2026 Hims & Hers agreed to buy it for $1.15 billion (A$1.6 billion).